SIRT6 and hepatocellular carcinoma: In this study, we performed a meta-analysis of nine studies including 867 cancer patients and found that high expression of SIRT6 was significantly related to longer OS time in gastrointestinal cancers including CRC, GC, PDAC, and HCC.